Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: A comparison of their effect on blood pressure during mental and physical activity  by Floras, John S. et al.
186 
HYPERTENSION 
JACC Vol. 6, No, I 
July 1985: 186--95 
Cardioselective and Nonselective Beta-Adrenoceptor Blocking Drugs in 
Hypertension: A Comparison of Their Effect on Blood Pressure 
During Mental and Physical Activity 
JOHN S. FLORAS, MD, DPHIL, FRCP(C), M. OSMAN HASSAN, MB, BS, PHD, 
JOHN VANN JONES, MRCP, PHD, PETER SLEIGHT, MD, OM, FRCP, FACC 
Headington. Oxford. United Kingdom 
The ability of cardioselective and nonselective beta-ad-
renoceptor blocking drugs, with and without partial ag-
onist activity, to control increases in blood pressure as-
sociated with mental and physical activity was compared 
in 3S subJects with hypertension. Direct measurements 
of blood pressure and radioenzymatic determinations of 
plasma norepinephrine were obtained before, during and 
after four activities, and were repeated after random 
allocation to treatment with atenolol, metoprolol, pin-
dolol or propranolol. 
Cardioselective and nonselective drugs modestly re-
duced the pressor response to reaction time testing, but 
not to mental arithmetic or isometric exercise. The in-
crease in systolic blood pressure during bicycling was 
attenuated significantly by the cardioselective drugs 
atenolol (by 23 mm Hg, or 38%) and metoprolol (21 mm 
Cardioselective and nonselective beta-adrenoceptor block-
ing agents are equally effective in lowering the blood pres-
sure at rest of subjects with hypertension (1,2). Differences 
in the antihypertensive potential of these drugs may be dif-
ficult to detect under rest conditions, however, but emerge 
with sympathoadrenal activation because nonselective beta-
blocking drugs favor vasoconstriction in the presence of 
circulating epinephrine by inhibiting betarmediated vaso-
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Hg, or 41 %), but not by the nonselective agents pindolol 
(with partial agonist activity) (13 mm Hg, or 20%) and 
propranolol (10 mm Hg, or 17%) (p < 0.02 cardiose-
lective versus nonselective; p = NS pindolol versus pro-
pranolol). Only bicycle exercise increased plasma nor-
epinephrine concentrations (by 80%). 
These results suggest that beta-adrenoceptor blocking 
drugs will not attenuate increases in blood pressure dur-
ing mental or physical activities unless intense sympa-
thoadrenal activation also occurs. Marked elevations in 
circulating epinephrine, with or without norepineph-
rine, and peripheral betarblockade appear necessary for 
alpha-mediated vasoconstriction to predominate and for 
the contrasting effects of cardioselective and nonselective 
drugs to be appreciated. 
(J Am Coil CardioI1985;6:186-95) 
dilation in peripheral resistance vessels (3), The relative 
ability of these drugs to reduce increases of blood pressure 
during normal daily activity, as opposed to their influence 
on arterial pressure at rest, is as yet not well documented. 
We undertook this comparison of the ability of long-term 
cardioselective and nonselective beta-adrenergic blockade 
to alter increases in blood pressure during mental and phys-
ical activities with three objectives: to determine I) whether 
increases in blood pressure with these activities could be 
attenuated by beta-blockade, 2) whether cardioselective and 
nonselective beta-blocking agents differed in their ability to 
effect such attenuation, and 3) the influence of partial agonist 
activity on these changes. To avoid the error and uncertainty 
that arises whenever blood pressure is determined nonin-
vasively, particularly during exercise, we performed in-
traarterial recordings. 
Methods 
Subjects. Thirty-five subjects with newly diagnosed, 
untreated, essential hypertension were studied; there were 
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24 men and 11 women aged 16 to 69 years (mean 47.8, 
SD ± 12.3). Blood pressure was measured on three or more 
clinic visits using a standard mercury sphygmomanometer 
(Accoson) after 10 minutes of quiet rest. Phase V of the 
Korotkoff sounds was used to record diastolic blood pres-
sure. Cuff blood pressures of 140/90 mm Hg or greater in 
patients less than 40 years of age and of 160/95 mm Hg or 
greater in patients aged 40 years or more established the 
presence of high blood pressure. Subjects with secondary 
causes of hypertension were excluded. The average blood 
pressure (mean ± SD) on the final clinic visit before entry 
into the study was 176 ± 2411 07 ± II mm Hg. 
Protocol. Subjects arrived at 9:30 AM after a light break-
fast at home, avoiding tea, coffee and cigarettes. There were 
no other dietary restrictions. 
Under local anesthesia a flexible Teflon cannula (II cm 
long, external diameter 1.0 mm, internal diameter 0.6 mm; 
Seldicath) was placed in the left brachial artery using the 
Seldinger technique and connected by way of a 200 cm 
manometer line to a strain gauge transducer (Statham P23 
Gb or Gould Statham P23 ID). The line was flushed inter-
mittently with heparinized dextrose solution. 
A second cannula was inserted into an adjacent antecu-
bital vein and connected by a three-way stopcock to a second 
manometer line, also connected to a dextrose solution. The 
arterial and venous cannulas, stopcock and part of the ma-
nometer lines were taped to the subject's forearm, permitting 
free arm movement. The arterial pressure transducer was 
positioned at the patient's mid chest level and calibrated to 
o and 200 mm Hg using a mercury column (Accoson). 
Calibrations were repeated each time the subject changed 
position and at the end of the study. 
The electrocardiogram (lead II) and blood pressure were 
displayed on an oscilloscope and recorded continuously onto 
ultraviolet light-sensitive paper, magnetic tape (Racal Ther-
mionic Store-4) and into a minicomputer (Data General 
Eclipse S-200). 
Blood pressure and heart rate during mental and 
physical exercise. Baseline supine blood pressure and heart 
rate were recorded after approximately 15 minutes of quiet 
rest. Four activities were performed in the same sequence 
by all subjects: mental arithmetic, a reaction time test, iso-
metric exercise and bicycling. After a baseline 90 second 
recording, the nature of the test to follow was explained. 
After a 30 second interval, the exercise began. At the end 
of each activity, the patient was instructed to relax and was 
monitored until blood pressure and heart rate returned to 
baseline levels. Then he or she was prepared for the next 
study. Mental arithmetic and the reaction time test were 
performed with the patient supine, isometric and bicycling 
exercises with the subject seated. 
Mental arithmetic consisted of subtracting the number 7 
serially from 300. As the subject called out each answer he 
was criticized for tardiness or for making errors. 
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A timer counter (RACAL Instruments. 9835) was con-
vered to a reaction time testing device by obscuring all but 
the first number of the digital display with a card. The 
subject was shown two buttons on the timer counter marked 
"start" and "stop." When the start button was pressed, 
the number on the digital display changed sequentially. When 
the stop button was pressed, this number was frozen. The 
subject was instructed to press the start button and wait till 
the investigator called out a number at random. He was to 
freeze this number the instant it appeared by pressing the 
stop button, and then immediately restart the timer. For the 
first 2.5 minutes the displayed numbers changed each second 
(slow sequence) and for the next 2.5 minutes they changed 
at a speed of lOis (fast sequence). 
The apparatus used for the isometric exercise was a 
sphygmomanometer bulb attached to an air pressure gauge 
which displayed grip strenth in pounds/inch2. The subject 
was asked to grasp the bulb with the noncannulated hand, 
squeeze it with maximal effort for 30 seconds, then release 
his grip slowly to 30% of his maximal voluntary capacity. 
This level of pressure, usually 3 to 5 pounds/inch2 (200-
350 g/cm2 ), was sustained for as long as possible up to 4.5 
minutes. Subjects were instructed to breathe naturally to 
avoid performing a Valsalva maneuver during handgrip. 
The patient then sat on a bicycle ergometer (Tunturi) 
whose work load (calibrated for a speed of 18 kmlh at 50 
rpm) could be controlled by adjusting a brake. Subjects 
bicycled without gripping the handlebars for 5 minutes at 
50 watts (300 kmlh per min), then for 5 minutes at 75 watts 
(450 kmlh per min) and then rested until blood pressure and 
heart rate returned to baseline levels. 
Analysis of blood pressure and heart rate during men-
tal and physical exercise. The blood pressure signal was 
sampled by an analog-digital converter at a frequency of 
100 Hz. A second channel of the converter was used for an 
event switch, which marked periods of rest and exercise. 
Systolic, mean and diastolic blood pressures, as well as the 
pulse interval, were calculated on a beat to beat basis using 
a suite of multi-tasking real time Fortran IV blood pressure 
analysis programs. These four variables, along with the 
event mark, were inscribed in expanding page format on a 
visual display unit (Tektronix 4006-1). 
At the end of each exercise, the average systolic, mean 
and diastolic pressures, their standard deviations and the 
average pulse interval with its standard deviation were cal-
culated for each 15 second segment of the recording. The 
minimum, maximum and mean of each of these four values 
for each period of the exercise (that is, baseline, exercise 
and recovery) were also computed and printed (Digital 
Decwriter III). 
Definitions. Baseline blood pressures, pulse intervals or 
heart rates were defined as the mean of all cardiac cycles 
recorded during the rest period (usually 1.5 minutes) before 
the explanation or initiation of an exercise. Exercise blood 
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pressure, pulse interval or heart rate values represented the 
highest (or lowest, in the case of pulse interval) mean values 
recorded during each 15 second segment of exercise. Re-
covery values were obtained from the 15 second segment 
occurring 3 minutes after the end of each activity. 
Effect of beta-blockade on blood pressure and heart 
rate during mental and physical exercise. After the ex-
ercise studies were completed, patients were randomized to 
one of four beta-adrenoceptor blocking drugs, namely, aten-
0101 (n = 9) and metoprolol (n = 9) (cardioselective beta,-
blocking agents), and pindolol (n = 9) and slow release 
propranolol (n = 8) (4), nonselective beta-blocking agents 
with (pindolol) and without (propranolol) partial agonist 
activity. All drugs were to be taken once daily in the morn-
ing. Although multiple daily dosings are recommended for 
metoprolol and pindolol, we have shown, by direct 24 hour 
ambulatory monitoring, that significant reductions in blood 
pressure can be maintained by each of these four drugs when 
taken once daily (5). Further, after long-term once daily 
therapy, the time course of the effect these drugs have on 
blood pressure and heart rate is independent of their plasma 
concentration (6). 
The initial dose of each drug was: atenolol, IOO mg; 
metoprolol, 200 mg; pindolol, 15 mg and slow release pro-
pranolol, 160 mg. The manufacturers provided white un-
marked formulations. The randomization schedule was held 
in the hospital pharmacy. 
The patients were evaluated subsequently at monthly in-
tervals at the same time of day. If, on these visits, a cuff 
blood pressure of 140/90 mm Hg or less was not achieved, 
the dose was increased as follows: atenolol, to 200 mg; 
metoproiol, to 300, then 400 mg; pindolol, to 30, then 45 
mg and slow release propranolol, to 320, then 480 and then 
640 mg (all to be taken once daily). Doses were not in-
creased beyond these levels even if the blood pressure re-
mained above 140190 mm Hg. Because of fatigue, the dose 
of atenolol was reduced to 50 mg in one subject. This 
symptom resolv<;:d and his blood pressure remained under 
control. 
After a mean of 5 months of treatment, the protocol was 
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repeated at the same time of day as on the first study (control). 
The assigned drug was taken as usual at 8 AM. The average 
dose of each drug before the second study was: atenolol, 
128 ± 56 mg (mean ± SD); metoprolol, 311 ± 105 mg; 
pindolol, 33 ± 10 mg and slow release propranolol, 440 
± 156 mg. (Table 1). All four drugs were equally well 
tolerated and no one was withdrawn from the study because 
of side effects from the medication. The arterial cannulations 
were performed without complication. 
Consent. The purpose and nature of the protocol were 
explained on recruitment, and again on the morning of the 
first study, when informed written consent was obtained. 
Consent was also obtained before the second study, that is, 
after randomization to long-term treatment. Permission for 
these investigations was granted by the Hospital Ethics 
Committee. 
Estimation of plasma norepinephrine concentra-
tions. Venous blood was obtained for plasma norepineph-
rine determination on control and treatment study days after 
15 minutes of sitting quietly, during the last minute of handgrip 
(n = 27), during the last minute of bicycle exercise (n = 
25) and then 3 minutes after the completion of each of these 
exercises. During the control studies blood was also drawn 
from five subjects after 15 minutes of supine rest, during 
the last minute of mental arithmetic and 3 minutes afterward. 
Plasma norepinephrine concentrations were determined us-
ing a radioenzymatic assay (7). The mean coefficient of 
interassay variation was 9.4%. 
Statistics. We used Stildent's t test for paired data when 
making control versus treatment comparisons within each 
of the four groups. Analysis of variance and covariance 
were used for comparisons between drugs. The data were 
found to be normally distributed. Means and standard de-
viations are described throughout. 
Results 
Patient randOinization. The patients' ages and clinic 
blood pressures before randomization (control study) were 
similar within each of the four groups. Clinic blood pres-
sures before the second (or treatment) study, the mean dose 
Table 1. Age, Clinic Blood Pressures and Dose and Duration of Beta-Adrenergic Blockade in 35 Patients 
Mean Clinic Blood 
Mean Clinic Blood Pressure Before p Value (paired Dose on Duration of 
Treatment Pressure Before First Second Study Student's t test, Second Beta-Blockade 
Group Age (yr) Study (mm Hg) (mm Hg) one-tailed) Study (mg) (mo) 
Atenolol 48.2 ± 10.8 173 ± 26/107 ± 9 143 ± 32/90 ± 20 0.01/0.05 128 ± 56 4.8 ± 1.4 
(n = 9) 
Metoprolol 44.8 ± 14.4 169 ± 20/102 ± 4 160 ± 25/96 ± 14 NS/O.05 311 ± 105 5.0 ± 1.3 
(n = 9) 
Pindolol 50.7 ± 14.0 179 ± 26/111 ± 10 150 ± 27198 ± 13 0.01/0.05 33 ± 10 5.3 ± 1.5 
(n = 9) 
Propranolol 44.8 ± 8.8 182 ± 24/109 ± 16 149 ± 25/94 ± 8 0.05/0.05 440 ± 186 4.9 ± 1.8 
(slow release) 
(n = 8) 
Values are expressed as mean ± SO. 
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of each drug and duration of therapy are listed in Table 1, 
Mental arithmetic. The baseline mean arterial pressure, 
measured at rest before mental arithmetic, was significantly 
lowered by each of the four drugs (atenolol, 14 mm Hg; 
metoprolol, 10 mm Hg; pindolol, 21 mm Hg and slow 
release propranolol, 17 mm Hg), 
The increase in heart rate during mental arithmetic was 
reduced to a similar degree by all four drugs (atenolol, 53%; 
metoprolol, 67%; pindolol, 67% and slow release propran-
0101,47%), With the exception of atenolol, which blunted 
the increase in systolic blood pressure during mental arith-
metic by 6 ± 7 mm Hg (p = 0,022), the increase in blood 
pressure during mental arithmetic was not attenuated by any 
of these four drugs, However, this effect of atenolol on 
systolic blood pressure was not significantly different from 
that of the other drugs when assessed by analysis of variance 
(Table 2), 
In five subjects studied before treatment assignation, plasma 
norepinephrine concentrations measured at the end of mental 
arithmetic were identical to baseline values (Table 3), 
Reaction time testing. Mean arterial pressure, mea-
sured at rest before this test, was significantly reduced by 
treatment with atenolol (17 mm Hg), pindolol (20 mm Hg) 
and slow release propranolol (19 mm Hg), but not in this 
instance by metoprolol (7 mm Hg). However, metoprolol 
achieved a 69% reduction in the increase in heart rate evoked 
by reaction time testing, compared with 36, 50 and 53% 
for the other three drugs, respectively, Therefore, it ap-
peared that adquate beta,-blockade was achieved by this 
dose of metoproloL 
The increase in blood pressure caused by the reaction 
FLORAS ET AL. 189 
BETA-ADRENERGIC BLOCKADE AND BLOOD PRESSURE 
time test was slightly but significantly attenuated by beta-
blockade when the results in the 35 subjects were combined, 
but not in the individual groups (Table 4), Atenolol blunted 
the increase in diastolic blood pressure by 3 ± 4 mm Hg 
(p = 0,024); this was not significantly different from the 
effect of the other three drugs on diastolic pressure (analysis 
of variance), 
Isometric exercise. All four drugs reduced mean arterial 
pressure at rest (measured with patients seated, before iso-
metric exercise) by 16 or 17 mm Hg and reduced the increase 
in heart rate during isometric exercise to a similar extent 
(atenolol, 45%; metoprolol, 50%; pindolol, 44% and slow 
release propranolol, 43%, respectively). The increase in 
blood pressure with isometric exercise was not altered by 
beta-blockade (Table 5). 
Isometric exercise did not significantly increase plasma 
norepinephrine concentrations above baseline values, either 
before or after beta-blockade (Table 3). Plasma norepi-
nephrine concentrations tended to be higher after treatment, 
but not to a significant degree. 
Bicycle exercise. The cardioselective and nonselective 
beta-adrenoceptor blocking drugs had similar (significant) 
effects on the mean arterial pressure at rest before bicycling, 
which was lowered by 17, 17, 22 and 22 mm Hg, respec-
tively, in each group (atenolol, metoprolol, pindolol and 
slow release propranolol). All four drugs reduced the in-
crease in heart rate with bicycle exercise to a similar degree 
(33,30,33 and 38%). 
In the 33 subjects combined, bicycling increased the blood 
pressure by 60 ± 18118 ± 9 mm Hg before and by 43 ± 
21115 ± 9 mm Hg subsequent to beta-blockade (Table 6). 
Table 2. Beta-Blockade and Blood Pressure and Heart Rate Responses to Mental Arithmetic 
Control Treatment Change in Variable 
Treatment (SBP, DBP and HR) 
Group Variable Rest MA t1 Rest MA t1 With Treatment Value 
Atenolol SBP 166 ± 29 195 ± 34 29 ± 9 151 ± 33 174 ± 36 23 ± 10 -6 ± 7 0,022 
(n = 9) DBP 89 ± 11 105 ± 13 16 ± 4 76 ± 11 89 ± 11 13 ± 5 -3 ± 6 NS 
HR 77 ± 14 96 ± 13 19 ± 7 60 ± 12 69 ± 15 9 ± 5 -10 ± 6 0.001 
Metoprolol SBP 168 ± 32 196 ± 34 28 ± 15 158 ± 31 191 ± 47 33 ± 23 +5 ± 16 NS 
(n = 9) DBP 87 ± 15 109 ± 26 22 ± 13 79 ± 14 101 ± 26 22 ± 17 o ± 6 NS 
HR 69 ± 7 90 ± 17 21 ± 13 56 ± 7 63 ± 9 7 ± 6 -14 ± 10 0.004 
Pindolol SBP 174 ± 26 215 ± 28 41 ± 14 145 ± 29 184 ± 33 39 ± 21 -2 ± 11 NS 
(n = 9) DBP 91 ± 8 112 ± 8 21 ± 6 76 ± II 99 ± 13 23 ± II +2 ± 6 NS 
HR 71 ± II 95 ± 18 24 ± 11 66 ± 8 74 ± 12 8 ± 9 -16 ± II 0.002 
Propranolol SBP 166 ± 26 198 ± 22 32 ± 14 145 ± 18 176 ± 24 31 ± 14 -I ± 14 NS 
(slow release) DBP 90 ± 15 108 ± II 18 ± 5 77 ± 10 96 ± 11 19 ± 7 + 1 ± 6 NS 
(n = 8) HR 80 ± 8 99 ± 10 19 ± 6 61 ± 8 71 ± II 10 ± 6 -9 ± 5 0.001 
All subjects SBP 169 ± 27 202 ± 30 33 ± 14 150 ± 28 182 ± 35 32 ± 18 -I ± 13 NS 
(n = 35) DBP 89 ± 12 108 ± 16 19 ± 8 76 ± II 96 ± 17 20 ± 11 + 1 ± 6 NS 
HR 74 ± 11 95 ± 15 21 ± 10 61 ± 10 69 ± 12 8 ± 6 -13 ± 8 0.001 
Values are expressed as mean ± standard deviation. t1 = change in variable (SBP, DBP and HR); DBP = diastolic blood pressure (mm Hg); 
HR = heart rate (beats/min); MA = mental arithmetic; SBP = systolic blood pressure (mm Hg). Student's paired t test, two tailed. 
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Table 3. Plasma Norepinephrine Concentrations (pg/ml) at Rest and During Exercise Before and After Beta-Adrenergic Blockade 
Control Treatment 
Activity Rest Activity p Value Rest Activity p Value 
Mental arithmetic 554 :':: 219 555 :':: 248 NS 
(n = 5) 
Isometric exercise 689 :':: 241 738 :':: 275 NS 732 :':: 299 792 :':: 340 NS 
(n = 27) 
Bicycle exercise 644 :':: 213 1,170 :':: 464 0.001 768 :':: 335 1,387 :':: 587 0.001 
(n = 25) 
Values are expressed as mean:':: SO. Student's t test, two-tailed, - = not measured. 
This 17 ± 24 mm Hg attenuation of the increase in systolic 
blood pressure was significant (p < 0.001); that of the 
diastolic blood pressure, 3 ± 10 mm Hg, was not. Bicycle 
exercise increased systolic blood pressure before and after 
treatment in each of the four groups as follows: atenolol, 
60 and 37 mm Hg; metoprolol, 51 and 30 mm Hg; pindolol, 
64 and 51 mm Hg and slow release propranolol, 64 and 54 
mm Hg (Table 6, Fig. 1). 
The increases in systolic blood pressure with bicycling 
were attenuated significantly in subjects taking the cardio-
selective drugs atenolol (38%; p < 0.002) and metoprolol 
(41 %; p < 0.001), but not in those taking the nonselective 
drugs pindolol (20%) and slow release propranolol (17%) 
(Fig. 2). In two patients taking pindolol and one taking slow 
release propranolol, there was a greater increase in systolic 
blood pressure with exercise after treatment than before 
(Fig. 1). The difference between the effect of the cardiose-
lective and nonselective drugs on the increase in systolic 
blood pressure with bicycle exercise was significant (p < 
0.02), using analysis of covariance, with the control values 
as covariants, to adjust for the different increases in blood 
pressure observed within each of the four groups before 
treatment. 
A significant blunting of the increase in diastolic blood 
pressure with bicycle exercise was seen in those subjects 
taking atenolol, but this attenuation (16 ± 7 mm Hg) did 
not differ from the effects of the other three drugs (analysis 
of variance). 
Submaximal bicycle exercise increased plasma norepi-
nephrine concentrations substantially, both before and after 
treatment (Table 3). Plasma norepinephrine concentrations 
tended to be higher after beta-adrenergic blockade, both at 
rest and during exercise. 
Discussion 
Cardioselective versus nonselective beta-adrenocep-
tor blocking drugs. Clinical data suggest that the differing 
affinities of cardioselective and nonselective beta-adreno-
ceptor blocking drugs for peripheral betarreceptors, me-
Table 4. Beta-Blockade and Blood Pressure and Heart Rate Responses to a Reaction Time Test 
Control Treatment Change in Variable 
Treatment (SBP, DBP and HR) 
Group Variable Rest RTT a Rest RTT a With Treatment p Value 
Atenolol SBP 174 :':: 30 196 :':: 34 22 :':: II 154 :':: 33 17l :':: 38 17 :':: 10 -5 :':: 8 NS 
(n = 9) DBP 94 :':: I3 108 :':: 16 14 :':: 5 79 :':: 12 90:':: 13 II :':: 6 -3 :':: 4 0.024 
HR 77 :':: 14 91 :':: 13 14:':: 4 60:'::10 69 :':: 20 9 :':: II -5 ± 13 0.34 
Metoprolol SBP 174 :':: 27 204 ± 34 30:':: 14 167 :':: 38 194 ± 40 27 ± 2 -3 :':: 6 NS 
(n = 9) DBP 91 ± 13 110 :':: 17 19 :':: 8 86 :':: 20 102 ± 20 16 ± 6 -3 :':: 6 NS 
HR 70 :':: 18 83 ± 12 13 ± 6 55 ± 7 59 :':: 8 4 :':: 2 -9 ± 4 0.001 
Pindolol SBP 181 ± 28 211 :':: 27 30 ± 9 151 :':: 28 175 :':: 31 24 ± 14 -6 ± 10 NS 
(n = 9) DBP 95 ± 8 114 ± 9 19 ± 10 81 ± 13 97 ± 13 16 ± 10 -3 ± 5 NS 
HR 71 ± 12 87 ± 16 16 ± 6 65 ± 8 73 ± 9 8 ± 5 -8 ± 4 0.001 
Propranolol SBP 175 ± 27 201 ± 23 26 ± 7 151 ± 18 177 ± 22 26 ± 9 o ± 9 NS 
(slow release) DBP 95 ± 15 III ± 15 16 ± 6 81 ± 9 97 ± 11 16 ± 6 o ± 5 NS 
(n = 8) HR 79 ± 8 94 ± 10 15 ± 6 61 ± 8 68 ± 9 7 ± 3 -8 ± 6 0.009 
All subjects SBP 176 ± 27 203 ± 29 27 ± II 155 ± 30 179 ± 34 24 ± 12 -3 ± 8 0.032 
(n = 35) DBP 94 ± 12 III ± 14 17 ± 8 82 ± 14 97 ± 15 15 ± 7 -2 ± 5 0.013 
HR 74 ± 11 88 ± 13 14 ± 5 60 ± 9 67 ± 12 7 ± 6 -7 ± 8 0.001 
RTT = reaction time test; other abbreviations and statistics as in Table 2. 
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Table 5. Beta-Blockade and Blood Pressure and Heart Rate Responses to Isometric Exercise 
Treatment 
Group 
Atenolol 
(n = 9) 
Metoprolol 
(n = 8) 
Pindolol 
(n = 9) 
Propranolol 
(slow release) 
(n = 8) 
All subjects 
(n = 34) 
Variable 
SBP 
DBP 
HR 
SBP 
DBP 
HR 
SBP 
DBP 
HR 
SBP 
DBP 
HR 
SBP 
DBP 
HR 
Rest 
160 ± 28 
90 ± II 
80 ± 12 
175 ± 26 
93 ± 15 
73 ± 7 
162 ± 30 
87 ± II 
73 ± 15 
165 ± 30 
93 ± 19 
84 ± 12 
165 ± 28 
91 ± 14 
78 ± 12 
Abbreviations and statistics as in Table 2, 
Control 
Exercise 
202 ± 38 
117 ± 16 
102 ± 16 
221 ± 32 
119 ± 18 
85 ± 10 
212 ± 35 
117 ± 13 
91 ± 15 
109 ± 32 
115 ± 20 
98 ± 13 
211 ± 34 
117 ± 16 
95 ± 15 
42 ± 20 
27 ± II 
22 ± 10 
46 ± 12 
26 ± 6 
12 ± 5 
50 ± 13 
30 ± 8 
18 ± 4 
44 ± 15 
22 ± 7 
14 ± 5 
46 ± 15 
26 ± 9 
17 ± 7 
diators of vasodilation in resistance vessels, place nonse-
lective beta-blocking drugs at a theoretical, rather than an 
actual, disadvantage in the treatment of high blood pressure 
(1,2). Any therapeutic benefit arising from cardioselectivity 
may be difficult to detect if subjects are studied at rest, but 
emerge when sympathoadrenal discharge is increased, for 
instance, by mental or physical activity. At these times, the 
ability of cardioselective and nonselective beta-blocking agents 
Treatment 
Rest Exercise 
143 ± 34 189 ± 42 
74 ± 14 103 ± 15 
58 ± 6 70 ± 10 
155 ± 23 206 ± 33 
80±15108±18 
53 ± 8 59 ± 10 
138 ± 30 184 ± 30 
76 ± 12 103 ± 13 
66 ± 8 76 ± II 
144 ± 22 188 ± 35 
80 ± II 104 ± 16 
62 ± 7 70 ± 7 
145 ± 27 192 ± 35 
77 ± 13 104 ± 15 
60±8 69±1I 
46 ± 21 
29 ± 10 
12 ± 5 
51 ± 14 
28 ± 7 
6 ± 4 
46 ± 14 
27 ± 8 
10 ± 4 
44 ± 23 
24 ± 9 
8 ± 2 
47 ± 18 
27 ± 9 
9 ± 4 
Change in Variable 
(SBP, DBP and HR) 
With Treatment 
+4 ± 16 
+2 ± 6 
-10 ± 8 
+5 ± 17 
+2 ± 8 
-6 ± 4 
-4 ± 21 
-3 ± II 
-8 ± 4 
o ± 20 
+2 ± 8 
-6 ± 5 
+ I ± 18 
+ I ± 8 
-8 ± 6 
p Value 
NS 
NS 
0,01 
NS 
NS 
0,003 
NS 
NS 
0,001 
NS 
NS 
0,007 
NS 
NS 
0,001 
to blunt increases in blood pressure could differ, particularly 
if circulating catecholamines are increased, because an in-
hibition of betarmediated vasodilation by nonselective drugs 
would permit alpha-adrenoceptor-mediated vasoconstric-
tion to predominate. There is evidence to support this hy-
pothesis. After propranolol is administered intravenously or 
orally, an infusion of epinephrine will increase rather than 
decrease forearm vascular resistance, whereas after acute 
Table 6. Beta-Blockade and Blood Pressure and Heart Rate Responses to Bicycle Exercise 
Drug 
Atenolol 
(n = 9) 
Metoprolol 
(n = 8) 
Pindolol 
(n = 9) 
Propranolol 
(slow release) 
(n = 7) 
All subjects 
(n = 33) 
Variable 
SBP 
DBP 
HR 
SBP 
DBP 
HR 
SBP 
DBP 
HR 
SBP 
DBP 
HR 
SBP 
DBP 
HR 
Rest 
162 ± 35 
91 ± 15 
83 ± 14 
173 ± 28 
92 ± \3 
76 ± 8 
159 ± 35 
87 ± 14 
76 ± 16 
171 ± 40 
96 ± 15 
87 ± 9 
166 1: 33 
91 ± 14 
80 ± \3 
Abbreviations and statistics as in Table 2. 
Control 
Exercise 
222 ± 40 
108 ± 10 
137 ± 13 
224 ± 36 
106 ± 16 
112 ± 15 
223 ± 50 
109 ± 25 
124 ± 28 
235 ± 23 
114 ± 12 
143 ± 21 
226 ± 38 
109 ± 17 
129 ± 13 
60 ± 16 
17 ± 8 
54 ± 14 
51 ± \3 
14 ± 6 
36 ± 9 
64 ± 23 
22 ± 14 
48 ± 9 
64 ± 21 
18 ± 6 
56 ± 17 
601: 18 
18 ± 9 
49 ± 16 
Rest 
144 ± 38 
76 ± 15 
58 ± 7 
154 ± 29 
78 ± 14 
54 ± 8 
127 ± 27 
71 ± 15 
66 ± 9 
136 ± 25 
77 ± 14 
62 ± 7 
140 ± 31 
75 ± 14 
60 ± 9 
Treatment 
Exercise 
181 ± 38 
87 ± 12 
94 ± 8 
184 ± 32 
90 ± 16 
79 ± 10 
178 ± 49 
88 ± 24 
98 ± 16 
190 ± 28 
97 ± 17 
97 ± 15 
183 ± 37 
90 ± 18 
92 ± 14 
37 ± 10 
\I ± 8 
36 ± 5 
30 ± 16 
12 ± 7 
25 ± 7 
51 ± 29 
17 ± 13 
32 ± 10 
54 ± 12 
20 ± 7 
35 ± 10 
43 ± 21 
15 ± 9 
32 ± 9 
Change in Variable 
(SBP, DBP and HR) 
With Treatment 
-23 ± 15 
-6 ± 7 
-18 ± 14 
-21 ± 10 
-2 ± 7 
-II ± 8 
-13 ± 35 
-5 ± 14 
-16 ± II 
-10 ± 31 
+2 ± 9 
-21 ± 5 
-17 ± 24 
-3 ± 10 
-17 ± 12 
p Value 
0.002 
0.035 
0.006 
0.001 
NS 
0.006 
NS 
NS 
0.002 
NS 
NS 
0.011 
0.001 
NS 
0.001 
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Figure 1. Increase in systolic blood pressure 
(6SBP) from rest values during bicycle ex-
ercise before (C) and after (Rx) beta-adreno-
ceptor blockade (Student's paired t test, two-
tailed). SR = slow release. 
6SBP 
mmHg 
100 
50 
r---- P<0.002---, r- P< 0.001--, r- P= 0.32-----, 
JACC Vol. 6, No. I 
July 1985:186--95 
r-P=0.44----, 
OL-__ ~ __ ~ ________ _L ____ L-______ ~ ____ ~ ______ ~ ____ ~ __ __ 
C & c & c & c & 
Atenolol 
or chronic metoprolol administration, a modest decrease in 
resistance occurs, and an increase in systolic blood pressure, 
observed if propranolol is given, is attenuated (3,8,9). Con-
trasting blood pressure responses are also evident when in-
sulin is infused into subjects pretreated with these two drugs 
(10,11). Lastly, an intravenous dose of propranolol has an 
effect intermediate between that of metoprolol and placebo 
in attenuating the increase in systolic blood pressure during 
submaximal bicycle exercise (12). 
Nonetheless, it has been difficult to detect differences in 
the ability of cardioselective and nonselective beta-adren-
ergic blocking agents to effect increases in blood pressure 
that occur with standing, the cold pressor test, handgrip or 
bicycle exercise (13-18). Morrison et al. (15), for example, 
found the effect of propranolol and metoprolol on the rest 
and exercise blood pressures of 13 subjects with hyperten-
sion to be similar during several of these activities. How-
ever, this study lacked a control or placebo period, blood 
pressure was measured indirectly and subjects were also 
taking diuretic drugs. 
Figure 2. Increase in systolic blood pressure (6SBP, 
mean ± SD) from rest levels during bicycle ex-
ercise before c::::J and after ({{{{::;:::J treatment: 
attenuation of this increase (decrease in 6SBP) by 
each of the four beta-adrenoceptor blocking agents. 
SR = slow release. 
~SBP 
mm Hg 
80 
60 
40 
20 
Fall in ~SBP 
with treatment 
Metoprolol Pindolol Propranolol SR 
Our study, which is the first to describe contrasting re-
sponses to these two classes of drugs, differs from previous 
investigations in two important respects: 1) the use of direct 
blood pressure recordings, and 2) the inclusion of a series 
of mental and physical activities that alter blood pressure 
and heart rate in different ways. In studies of this size, the 
inability of most previous investigators to detect effects of 
beta-adrenoceptor blocking agents on pressor responses to 
various activities may have been due to the observer and 
technical errors associated with indirect techniques of blood 
pressure determination, rather than the lack of a true effect. 
This is particularly important during exercise, when move-
ment, muscular work and ambient noise obscure the auditory 
signal, and when, in some subjects, there is no clear diastolic 
cessation of the Korotkoff sounds. Arterial recording also 
avoids any error that may arise from the presence of sig-
nificant differences within a particular subject between the 
indirect and intraarterial blood pressures. However, this in-
vasive technique does preclude the use of a crossover study 
design. Therefore, subjects were assigned at random to one 
24 21 
(mmHg) Atenolol Metoprolol Pindolol Propranolol SR 
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of the four drugs, forming groups with similar characteristics 
(Table 1). 
Effect of beta-blockade on pressor responses to mental 
and physical activity. Treatment with each of these four 
drugs achieved similar reductions in mean arterial pressure 
at rest. The reductions in heart rate during activity seen 
within each group suggest that an equivalent degree ofbeta,-
blockade was achieved by all four drugs. Had comparisons 
been made only on the basis of these measurements, no 
difference between the cardioselective and nonselective drugs 
would have been evident. 
The increases in systolic and diastolic blood pressures 
with mental arithmetic and isometric exercise were not at-
tenuated by beta-adrenergic blockade. However, because 
initial values at rest were lower, the peak blood pressures 
achieved with activity were similarly decreased. During re-
action time testing, we observed a smaller increase in blood 
pressure than with the other two exercises, an increase that 
was reduced modestly, yet significantly, by beta-adrenergic 
blockade. However, no difference between the cardioselec-
tive and nonselective beta-adrenoceptor blocking agents 
emerged during these three activities. Our findings are con-
sistent with those of other investigators, who have failed to 
detect any blunting of the increase in blood pressure evoked 
by mental arithmetic and isometric exercise with beta-ad-
renoceptor blocking agents, whether cardioselective or non-
selective (12,15,17-19). 
In contrast, the increase in systolic blood pressure seen 
during bicycle exercise was reduced by the cardioselective 
drugs, but not by pindolol or propranolol. In three subjects 
taking one of the latter drugs, a greater increase in systolic 
blood pressure during bicycle exercise was seen after treat-
ment than before. In one case a doubling (from 56 to 118 
mm Hg) and in another an almost fourfold increase (from 
20 to 75 mm Hg) was noted (Fig. I). This paradoxical 
hypertensive response, of some concern, suggests that un-
opposed alpha-mediated vasoconstriction may exert a sig-
nificant pressor effect on the exercise blood pressure of some 
subjects. On the whole, these three subjects were older (55, 
63 and 64 years) than the group mean age. However, these 
increases could not be predicted from their blood pressures 
or norepinephrine concentrations. 
Comparison with previous studies. Several studies have 
shown that the increase in systolic blood pressure with dy-
namic exercise can be modified by beta-adrenergic blockade 
(16,20-22), but cardioselective drugs display no superiority 
in this respect (17). Beta-blockade did not blunt increases 
in blood pressure during exercise in other studies (13,14,23). 
Our work differs from these studies in that: 1) Doses tended 
to be higher because the initial dose of each drug often 
failed to achieve its target antihypertensive effect after I 
month; although we did not measure drug concentrations in 
plasma or test for cardioselectivity of these drugs, previous 
authors (8,24) have demonstrated that the selectivity of aten-
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0101 and metoprolol is retained at these doses. 2) Subjects 
were treated for a longer period before restudy because the 
maximal hemodynamic responses to beta-adrenergic block-
ade often require more than 2 months to develop (6,20,25). 
3) Subjects were exercised at sub maximal work loads. 4) 
Arterial pressure was recorded directly. Except for the work 
of Atterhog et al. (20), who used invasive monitoring to~ 
study the hemodynamic effects of pindolol and obtained, 
results similar to ours, these studies measured blood pressure 
indirectly. We believe that our ability to detect these dif-
ferent responses was strengthened by the use of direct blood 
pressure recordings. 
Neural mechanisms during mental and physical ac-
tivities and effect of beta-receptor blockade. Our findings 
may be explained by 1) the differing neural and humoral 
pathways effecting the responses to these four mental and 
physical activities, and 2) by the extent to which these 
pathways may be modified by beta-adrenoceptor blockade. 
During the first three activities, vagal withdrawal and the 
stimulation of cardiac and peripheral sympathetic nerves' 
increase both cardiac output and peripheral resistance (2&-28). 
Norepinephrine is released from sympathetic nerves, but' 
not in amounts of sufficient to increase plasma concentra-
tions (29-33). The contribution of circulating catechol-
amines, particularly epinephrine, to these hemodynamic 
changes is small (30,32,34). The pressor response to iso--
metric exercise is modulated, in addition, by a reflex arising 
from contracting muscle (35). Lastly, the buffering effect 
of the arterial baroreflexes may be reset to maintain tissue 
perfusion during exercise; this latter suggestion remains con-
troversial (36). 
The extent to which these neural mechanisms can be 
modified by beta-adrenergic blockade is slight. Central 
suppression of sympathetic tone, or presynaptic inhibition 
of norepinephrine release, is not the principal mechanism 
by which these drugs decrease blood pressure, because no1'-
epinephrine release into plasma is not affected by betaJ ! 
adrenergic blockade (37). Thus, beta-adrenergic blockade' 
would not appear capable of attenuating increases in blood 
pressure during mental stress or isometric exercise, pressor 
responses mediated primarily through an increase in sym-
pathetic neural activity. Because little epinephrine circu-
lates, the presence of betaz-adrenoceptor blockade and the 
issue of cardioselectivity are unimportant. 
In contrast, bicycle exercise evokes more intense sym-
pathoadrenal discharge. Cardiac output increases, while' 
peripheral resistance decreases (38). At the work loads per-
formed in our study, dynamic exercise increases plasma' 
epinephrine concentrations markedly (31,39,40). Thus, one 
would expect betaz-adrenoceptor-mediated vasodilation to 
assume greatest physiologic importance during bicycle ex-
ercise. In this setting, peripheral betaz-blockade would am-
plify the response to alpha-adrenoceptor-mediated vaso-
constriction; this would be enhanced further by any 
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concomitant increase in plasma norepinephrine. We docu-
mented marked increases in plasma norepinephrine concen-
trations during bicycling, similar to those observed by others 
during bicycle or treadmill exercise at these work loads 
(31,39). If, as proposed, unopposed alpha-mediated vaso-
constriction occurs in nonselective beta-adrenergic blockade 
when plasma epinephrine is increased and is intensified by 
concurrent increases in plasma norepinephrine, a difference 
between the antihypertensive efficacy of nonselective and 
selective beta-adrenergic blocking drugs would be antici-
pated during bicycling but not during the first three activ-
ities. Houben et al. (9,18) suggest that there must be a two-
to fourfold increase in plasma epinephrine before differences 
between the effect of propranolol and metoprolol on blood 
pressure can be detected. 
These findings are consistent with data we derived from 
direct 24 hour ambulatory blood pressure recordings, where 
in any given subject the variability of arterial pressure, which 
reflects fluctuations in activity and autonomic nervous tone, 
is correlated positively with the pressor responses to each 
of these four physical and mental exercises (33), but is not 
influenced by these drugs (5). This would be expected if 
increases in blood pressure during most daily activities are 
not blunted by beta-adrenergic blockade. 
Influence of partial agonist activity. After long-term 
therapy with beta-adrenergic blocking drugs possessing par-
tial agonist activity, peripheral vascular resistance decreases 
and cardiac output returns to normal; forearm vascular re-
sistance, which remains elevated in subjects taking pro-
pranolol, decreases to or below control levels (20,41,42). 
Svensson et al. (16) found no difference between the effect 
of metoprolol and pindolol treatment on rest forearm vas-
cular resistance, and suggested that the partial agonist effect 
of pindolol on betaradrenoceptors would permit some pe-
ripheral vasodilation at rest and during exercise. However, 
Wilcox and Hampton (22) described a modest reduction of 
the increase in systolic blood pressure during exercise in 
subjects treated with atenolol and metoprolol but not with 
oxprenolol, another nonselective beta-blocking agent with 
partial agonist activity. In our study, blood pressure re-
sponses were similar in subjects treated with pindolol and 
propranolol, suggesting that the influence of partial agonist 
activity during exercise, when epinephrine-mediated vaso-
dilation would remain inhibited by the drug, is minor. 
Clinical implications. We have shown cardioselective 
beta-adrenergic blocking agents to be superior to nonselec-
tive drugs in blunting increases in blood pressure that occur 
during bicycle exercise. This is probably due to the marked 
sympathoadrenal activation, with significant increases in 
circulating epinephrine and norepinephrine, that occurs dur-
ing exercise. No differences in the antihypertensive effects 
of these drugs were evident with less strenuous physical 
activity or mental stresses. Cardioselective beta-adrenocep-
tor blockade may be preferable in situations when increases 
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in peripheral resistance and sympathoadrenal activity may 
be detrimental, for instance, in anterior myocardial infarc-
tion, acute aortic dissection or hypoglycemia, or during 
induction of anesthesia or in patients with angina who ex-
ercise, smoke (43) or drink caffeinated beverages (44). Al-
ternatively, in subjects with hypertrophic sub aortic stenosis, 
nonselective blockade might lessen the left ventricular out-
flow pressure gradient during exercise. These considerations 
await further assessment. 
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who administered the unmarked formulations; John Szalai, PhD for sta-
tistical advice; Chris Walton for technical and computing assistance and 
Beth Roberts, Mary Fouts and Nancy Stamp for expert typing. 
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